Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
Daily oral supplementation of glutamine with or without sitagliptin in well-controlled type 2 diabetes patients.
Semaglutide and dulaglutide administered weekly to adults with type 2 diabetes and obesity.
The study evaluated the addition of liraglutide to SGLT2 inhibitors and metformin in adults with type 2 diabetes, showing significant improvements in glycaemic control.
This study compared tirzepatide and dulaglutide in improving insulin sensitivity and beta-cell function in adults with type 2 diabetes, finding tirzepatide more effective.
This study compared once-weekly semaglutide to thrice-daily insulin aspart in adults with type 2 diabetes, revealing significant differences in HbA1c and body weight outcomes.
This study evaluated the impact of academic detailing and group visits on prescribing practices for Type 2 Diabetes, finding significant increases in metformin and insulin prescriptions.
This study compared the efficacy and safety of oral semaglutide to sitagliptin in adults with inadequately controlled type 2 diabetes. Results indicated that oral semaglutide led to significantly greater reductions in HbA1c and body weight.
This Phase II study evaluated the effects of Survodutide on HbA1c levels and bodyweight in adults with Type 2 Diabetes, finding significant reductions in both outcomes compared to baseline.
This study evaluated the effects of metformin delayed-release on glycemic control in adults with type 2 diabetes, showing significant reductions in HbA1c and fasting plasma glucose compared to placebo.
This study examined omentin-1 levels in patients with Type 2 Diabetes and their relationship to cardiac dysfunction, finding decreased levels linked to diastolic function.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
